Organization
Tohoku University Graduate School of Medicine
7 abstracts
Abstract
A mobile app–based program for facilitating advance care planning discussions between patients with advanced cancer and oncologists: A randomized controlled trial (J-SUPPORT 2104).Org: Institute for Cancer Control, National Cancer Center Hospital East, Kashiwa, Japan, Division of Survivorship Research, Division of Behavioral Sciences, Japanese Organisation for Research and Treatment of Cancer,
Abstract
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumor.Org: Juntendo University School of Medicine, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Hiroshima University, National Cancer Center Hospital Japan East, Kashiwa, Japan, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
The efficacy of hydrocolloid dressing as a prophylactic use for hand-foot skin reaction induced by multitargeted kinase inhibitors: A phase 3 randomized self-controlled study, J-SUPPORT 1701 APRON trial.Org: Gastrointestinal Medical Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan, Department of Nursing and Health Promotion, Group of Supportive Care and Survivorship Research, Institute for Cancer Control,
Abstract
Final three-year follow-up analysis of phase I/II study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.Org: Department of Neurosurgery, Peking Union Medical College Hospital, Beijing, China, Osaka International Cancer Institute, Osaka, Japan, Department of Neurosurgery and Neuro-Oncology, National Cancer Center Research Institute, Tokyo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Kyorin University Faculty of Medicine,
Abstract
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain.Org: National Cancer Center Japan, University of Notre Dame, Flinders University, Adelaide, SA, Australia, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Japanese Organisation for Research and Treatment of Cancer (JORTC) Data Center,
Abstract
Real-world efficacy of chemotherapy in patients with advanced extramammary Paget's disease: A retrospective, multicenter study of 204 Japanese patients.Org: Kumamoto University Hospital, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, Nagoya City University Graduate School of Medical Sciences, National Cancer Center Hospital East, Kashiwa, Japan, Graduate School of Medicine, Chiba University,
Abstract
First-line immune checkpoint inhibitors alone or in combination with chemotherapy in real-life elderly patients with advanced non-small cell lung cancer (NEJ057).Org: Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tohoku University Graduate School of Medicine, Nippon Medical School Hospital, Niigata University Graduate School of Medical and Dental Sciences, Japanese Red Cross Okayama Hospital,